Neuren Pharmaceuticals Limited(ASX:NEU) added to S&P/ASX 200 Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.8 AUD | +2.16% | +12.89% | -12.70% |
05-09 | Neuren Pharmaceuticals Partner Acadia Pharmaceuticals Posts US DAYBUE Sales of $75.9 Million | MT |
04-24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.70% | 1.82B | |
+35.01% | 709B | |
+30.78% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.42% | 239B | |
+9.49% | 211B | |
-4.38% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- Neuren Pharmaceuticals Limited(ASX: NEU) added to S&P/ASX 200 Index